CIK 0001877184 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
KESTRA MEDICAL TECHNOLOGIES, LTD.
Sign in to watch- Ticker
- KMTS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Apr 30
- Incorporated
- Bermuda
- Entity type
- operating
- Phone
- (425) 279-8002
- Business address
- 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND, WA, 98033
- 4 Open-market sale Chief Commercial Officer sold 27,632 shares at an average $23.25 ($642,523)
- 4 Open-market sale Chief Financial Officer sold 18,188 shares at an average $22.99 ($418,217)
- 4 Open-market sale See Remarks sold 22,229 shares at an average $23.07 ($512,791)
- 4 Open-market sale See Remarks sold 29,822 shares at an average $23.21 ($692,214)
- 4 Grant or award Chief Business Officer acquired 39,113 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 58,832 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 44,118 shares (grant or award)
- 4 Grant or award See Remarks acquired 58,832 shares (grant or award)
- 4 Planned sale See Remarks sold 15,000 shares at an average $22.44 ($336,609)
- 4 Grant or award Chief Business Officer acquired 227 shares (grant or award)
- 4 Grant or award See Remarks acquired 942 shares (grant or award)
- 4 Planned sale See Remarks sold 15,000 shares at $20.81 ($312,143)
- 4 Grant or award Chief Business Officer acquired 22,704 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 25,227 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 25,227 shares (grant or award)
- 4 Grant or award See Remarks acquired 25,227 shares (grant or award)
- 4 Grant or award See Remarks acquired 75,681 shares (grant or award)
- 4 Planned sale See Remarks sold 15,000 shares at an average $20.96 ($314,329)
- 4 Planned sale See Remarks sold 15,000 shares at $20.04 ($300,671)
- 4 Open-market buy Director bought 10,000 shares at $19.98 ($199,800)
Page 2 of 4 · 74 filings